COLLEGIUM PHARMACEUTICAL, INC - COLL

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 24, 2026 SCHEDULE 13G Integrated Core Strategies (US) LLC 5.4% 1,769,122 View
Aug 24, 2026 SCHEDULE 13G Millennium Management LLC 5.6% 1,820,330 View
Aug 24, 2026 SCHEDULE 13G Millennium Group Management LLC 5.6% 1,820,330 View
Aug 24, 2026 SCHEDULE 13G Israel A. Englander 5.6% 1,820,330 View
Aug 14, 2026 SCHEDULE 13G Fuller & Thaler Asset Management, Inc. 5.03% 1,632,781 View
Aug 05, 2026 SCHEDULE 13G PRINCIPAL GLOBAL INVESTORS 5.0% 1,632,360 View
Jul 31, 2026 SCHEDULE 13G Vanguard Capital Management 5.01% 1,625,821 View
May 15, 2026 SCHEDULE 13G JANUS HENDERSON GROUP PLC 5.8% 1,825,651 View
May 15, 2026 SCHEDULE 13G/A Eventide Asset Management, LLC 4.5% 1,424,282 View
May 15, 2026 SCHEDULE 13G/A Finny Kuruvilla, M.D. Ph. D. 4.5% 1,424,282 View
May 15, 2026 SCHEDULE 13G/A Robin C. John 4.5% 1,424,282 View
May 14, 2026 SCHEDULE 13G/A Renaissance Technologies LLC 4.53% 1,469,449 View
May 14, 2026 SCHEDULE 13G/A Renaissance Technologies Holdings Corporation 4.53% 1,469,449 View
May 12, 2026 SCHEDULE 13G Integrated Core Strategies (US) LLC 4.7% 1,515,406 View
May 12, 2026 SCHEDULE 13G Millennium Management LLC 4.7% 1,519,500 View
May 12, 2026 SCHEDULE 13G Millennium Group Management LLC 4.7% 1,519,500 View
May 12, 2026 SCHEDULE 13G Israel A. Englander 4.7% 1,519,500 View
Mar 26, 2026 SCHEDULE 13G/A The Vanguard Group 0.0% 0 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.